Geneos Wealth Management Inc. Eli Lilly & CO Transaction History

Geneos Wealth Management Inc.

$2.24 Billion
Q2 2024

A detailed history of Geneos Wealth Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 9,078 shares of LLY stock, worth $7.97 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

9,078

Previous 9,794 7.31%

Holding current value

$7.97 Million

Previous $7.62 Million 7.88%

% of portfolio

0.37%

Previous 0.35%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $519,006 - $650,872	-716 Reduced 7.31%	9,078 $8.22 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $333,408 - $446,053	563 Added 6.1%	9,794 $7.62 Million
Q4 2023 Jan 26, 2024	SELL	$525.19 - $619.13 $340,323 - $401,196	-648 Reduced 6.56%	9,231 $5.38 Million
Q3 2023 Oct 11, 2023	BUY	$434.7 - $599.3 $38,688 - $53,337	89 Added 0.91%	9,879 $5.31 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $575,915 - $770,065	1,642 Added 20.15%	9,790 $4.59 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $254,095 - $298,422	-818 Reduced 9.12%	8,148 $2.8 Million
Q4 2022 Jan 30, 2023	SELL	$321.55 - $374.67 $137,301 - $159,984	-427 Reduced 4.55%	8,966 $3.28 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.24 Million - $1.41 Million	-4,177 Reduced 30.78%	9,393 $3.04 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $86,963 - $102,108	-312 Reduced 2.25%	13,570 $4.4 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $237,740 - $295,451	-1,013 Reduced 6.8%	13,882 $3.98 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $288,257 - $357,729	-1,282 Reduced 7.92%	14,895 $4.11 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $24,819 - $30,543	-112 Reduced 0.69%	16,177 $3.71 Million
Q2 2021 Jul 08, 2021	BUY	$180.55 - $233.54 $499,040 - $645,504	2,764 Added 20.44%	16,289 $3.81 Million
Q1 2021 Jun 17, 2021	BUY	$164.32 - $212.72 $40,422 - $52,329	246 Added 1.85%	13,525 $2.47 Million
Q4 2020 May 19, 2021	SELL	$130.46 - $172.63 $32,484 - $42,984	-249 Reduced 1.84%	13,279 $2.37 Million
Q3 2020 Sep 07, 2021	SELL	$146.22 - $169.13 $80,421 - $93,021	-550 Reduced 3.91%	13,528 $2.03 Million
Q2 2020 Sep 07, 2021	SELL	$136.42 - $164.18 $14,460 - $17,403	-106 Reduced 0.75%	14,078 $2.29 Million
Q1 2020 Sep 07, 2021	BUY	$119.05 - $147.35 $23,690 - $29,322	199 Added 1.42%	14,184 $1.9 Million
Q4 2019 Sep 07, 2021	BUY	$106.92 - $132.43 $19,245 - $23,837	180 Added 1.3%	13,985 $1.84 Million
Q3 2019 Sep 07, 2021	SELL	$106.79 - $116.16 $1,067 - $1,161	-10 Reduced 0.07%	13,805 $1.55 Million
Q2 2019 Sep 07, 2021	BUY	$110.79 - $129.32 $47,528 - $55,478	429 Added 3.2%	13,815 $1.53 Million
Q1 2019 Sep 07, 2021	SELL	$111.31 - $131.02 $13,245 - $15,591	-119 Reduced 0.88%	13,386 $1.74 Million
Q4 2018 Sep 07, 2021	SELL	$105.9 - $118.64 $44,372 - $49,710	-419 Reduced 3.01%	13,505 $1.54 Million
Q3 2018 Sep 07, 2021	BUY	$85.86 - $107.31 $104,148 - $130,167	1,213 Added 9.54%	13,924 $1.49 Million
Q2 2018 Sep 07, 2021	SELL	$75.7 - $86.88 $31,794 - $36,489	-420 Reduced 3.2%	12,711 $1.08 Million
Q1 2018 Sep 07, 2021	SELL	$74.21 - $87.6 $26,196 - $30,922	-353 Reduced 2.62%	13,131 $1.02 Million
Q4 2017 Sep 07, 2021	SELL	$81.94 - $87.89 $103,572 - $111,092	-1,264 Reduced 8.57%	13,484 $1.14 Million
Q3 2017 Sep 07, 2021	BUY	$77.07 - $85.54 $19,575 - $21,727	254 Added 1.75%	14,748 $1.26 Million
Q2 2017 Sep 07, 2021	BUY	N/A	40 Added 0.28%	14,494 $1.19 Million
Q1 2017 Sep 07, 2021	SELL	N/A	-108 Reduced 0.74%	14,454 $1.22 Million
Q4 2016 Sep 07, 2021	BUY	N/A	650 Added 4.67%	14,562 $1.07 Million
Q3 2016 Sep 07, 2021	BUY	N/A	850 Added 6.51%	13,912 $1.12 Million
Q2 2016 Sep 07, 2021	BUY	N/A	214 Added 1.67%	13,062 $1.03 Million
Q1 2016 Sep 07, 2021	BUY	N/A	12,848	12,848 $943,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account

Geneos Wealth Management Inc. Eli Lilly & CO Transaction History